Observed incidence of hypofibrinogenemia in cirrhotic patients.

Usmani, Amena; Laknezhad, Soolmaz; De Simone, Nicole; Araj, Ellen; Sarode, Ravi

Usmani, Amena; Laknezhad, Soolmaz; De Simone, Nicole; Araj, Ellen; Sarode, Ravi.

Afiliação

Usmani A; Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Laknezhad S; Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
De Simone N; Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Araj E; Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Sarode R; Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.

Liver Int ; 41(10): 2523-2524, 2021 10.

Article em En | MEDLINE | ID: mdl-34403574

Assuntos

Afibrinogenemia; Afibrinogenemia/complicações; Afibrinogenemia/epidemiologia; Fibrinogênio; Humanos; Incidência; Cirrose Hepática/complicações; Cirrose Hepática/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Afibrinogenemia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google